Skip to main content
The American Journal of Pathology logoLink to The American Journal of Pathology
. 2010 May;176(5):2467–2476. doi: 10.2353/ajpath.2010.090519

Impaired Gastric Gland Differentiation in Peutz-Jeghers Syndrome

Lina Udd *, Pekka Katajisto *, Marika Kyyrönen *, Ari P Ristimäki †‡, Tomi P Mäkelä *
PMCID: PMC2861111  PMID: 20363912

Abstract

Gastrointestinal hamartomatous polyps in the Peutz-Jeghers cancer predisposition syndrome and its mouse model (Lkb1+/−) are presumed to contain all cell types native to the site of their occurrence. This study aimed to explore the pathogenesis of Peutz-Jeghers syndrome polyposis by characterizing cell types and differentiation of the epithelium of gastric polyps and predisposed mucosa. Both antral and fundic polyps were characterized by a deficit of pepsinogen C-expressing differentiated gland cells (antral gland, mucopeptic, and chief cells); in large fundic polyps, parietal cells were also absent. Gland cell loss was associated with an increase in precursor neck cells, an expansion of the proliferative zone, and an increase in smooth muscle α-actin expressing myofibroblasts in the polyp stroma. Lack of pepsinogen C-positive gland cells identified incipient polyps, and even the unaffected mucosa of young predisposed mice displayed an increase in pepsinogen C negative glands (25%; P = 0045). In addition, in small intestinal polyps, gland cell differentiation was defective, with the absence of Paneth cells. There were no signs of metaplastic differentiation in any of the tissues studied, and both the gastric and small intestinal defects were seen in Lkb1+/− mice, as well as polyps from patients with Peutz-Jeghers syndrome. These results identify impaired epithelial differentiation as the earliest pathological sign likely to contribute to tumorigenesis in individuals with inherited Lkb1 mutations.


Peutz-Jeghers syndrome (PJS), presents as a triad of characteristic polyps with branching smooth muscle core, mucocutaneous pigmentations, and a predisposition to cancer development.1,2,3 Peutz-Jeghers polyps have a properly polarized and apparently well-differentiated epithelium4 native to the site of occurrence.5,6 Although both polyps and carcinomas commonly arise in the gastrointestinal tract of PJS patients, the relationship between the two remains unclear. Inactivating mutations in the gene encoding for the LKB1 kinase cause PJS,1 and mice heterozygous for Lkb1 model the disease by developing multiple characteristic Peutz-Jeghers polyps, particularly in their gastric mucosa.7 The mechanism by which Lkb1 deficiency leads to polyps appears to involve the underlying stroma, based on polyps arising even when Lkb1 mutations are limited to the stromal smooth muscle lineage.8

The normal gastric mucosa consists of parallel bipartite units of basal glands and luminal pits. The appropriate cell type for each position in the unit is thought to depend on gradients of morphogens like Wnt, Hedgehog, bone morphogenetic protein, and transforming growth factor-ß,9,10,11 whose characteristic expression patterns are disrupted in gastric cancer or by inflammatory stimuli.12,13,14 The gastric gland is subdivided into isthmus, neck, and base regions. The isthmus contains stem cells,15 and a variety of precursor cells,16 which migrate bidirectionally out of the isthmus during differentiation. Throughout the stomach, pre-pit precursor cells move upwards to become Muc5a-secreting pit (foveolar) cells. Downward from the isthmus, cells migrate to form glands, specialized according to location. In the proximal glandular stomach, the glands are fundic (oxyntic), whereas pyloric antral glands cover the distal stomach. Acid-producing parietal cells17,18 are only found in fundic glands, whereas enteroendocrine cells producing gastrin are unique to antral glands. The similarities in migration and differentiation of the fundic zymogenic chief cells and antral pyloric gland cells are considerable. Fundic pre-neck cell precursors (corresponding to antral pre-gland cells) differentiate into mucin producing neck/mucous neck cells in the fundus (differentiating gland cells in the antrum),16 and further into mucopeptic (prezymogenic) cells in the fundus (pyloric gland cells in the antrum)16 as they migrate down. The mature, differentiated pyloric gland cells express pepsinogen C,19,20 mucin 6 (Muc6) and trefoil factor 2 (TFF2),21 that also mark early mucopeptic cells. The latter gradually transform from mostly mucin-producing cells into cells mostly producing proteolytic enzymes, reaching the base of the fundic gland as mature chief cells, no longer expressing mucin.16 In mouse, chief cells are also the major producers of intrinsic factor (IF),22 whereas human IF is expressed mainly, although not exclusively, in parietal cells.23 The signals mediating gland cell migration and differentiation in the distal stomach are only partially understood, but the transition from mucopeptic cells to chief cells requires the activity of transcription factor Mist124 and can be inhibited by stimulation of activin II receptor.25 The development and persistence of pepsinogen-expressing cells, and particularly chief cells, require glucocorticoids,26,27 whose homeostatic effects are mediated via the mesenchymal stroma.28

This stroma, the lamina propria, consisting of fibroblasts, endothelial, and immune cells, is located between and underneath the gastric units. The unit bases, the glands, are surrounded by a sheath of smooth muscle α-actin (SMA)-expressing intestinal subepithelial myofibroblasts,29 which, at least in the small intestine, link with the thin muscular sheath under the basal lamina called muscularis mucosae.30 In some pathological conditions of the gastric epithelium, like neo- or metaplasia31,32 or helicobacter gastritis,33 these myofibroblasts increase. In polyps of Peutz-Jeghers patients34 and Lkb1+/− mice,7 thick disorganized bundles of smooth muscle originating from the muscularis mucosae branch like a cauliflower stalk into polyp lobes. Here we studied the epithelia of gastric polyps and predisposed stomach in Lkb1+/− mice and Peutz-Jeghers patients to explore pathogenesis of Peutz-Jeghers polyps.

Materials and Methods

Animal and Clinical Specimens

Lkb1+/−35 and wild-type control mice in F1 and F2 C57BL6; CD1 backgrounds were sacrificed at an age of 4.5 months, or 10 to 11.5 months. Tissue specimens were collected and fixed in 4% paraformaldehyde for paraffin embedding as previously described.36 All animal experimentation was performed with permission from and in accordance with the recommendations of the local animal welfare committee at the University of Helsinki and State Provincial Office of Southern Finland. Paraffin-embedded samples of polyps and biopsies of normal gastric tissue from Peutz-Jeghers patients were obtained from the archives of the Helsinki University Central Hospital Pathology Department, in accordance with local ethical regulations.

Immunohistochemistry

All immunohistochemistry was performed on dewaxed and rehydrated sections, with endogenous peroxidase quenched by 3% hydrogen peroxide in either PBS or methanol. For staining against H+/K+-ATPase (HA3-923, Affinity Bioreagent, Golden, CO), Cdx2 (MU392A-U, BioGenex Laboratories, San Ramon, CA), chromogranin A (A0430, DakoCytomation, Carpinteria, CA), Muc6 (NCL-MUC-6, Novocastra, Newcastle On Tyne, UK), or Ki-67 (Clone TEC-3, DakoCytomation), sections were pre-treated with DAKO Target Retrieval (DakoCytomation) at 95°C, 20 minutes. H+/K+-ATPase signal was detected with the ARK-kit (DakoCytomation), whereas Ki-67 and CgA signal with biotinylated anti-rat- and anti-rabbit-antibodies (Vector Laboratories, Burlingame, CA), ABC-reagent (Vector) and diaminobenzidine substrate (Sigma-Aldrich, St. Louis, MO). Muc6 signal was detected with AlexaFluor488 conjugated anti-mouse antibody (Invitrogen, Carlsbad, CA). TFF2 (a kind gift by Dr. George Elia, Histopathology Unit, ICRF, London) and gastrin (A0568, DakoCytomation) antibodies were used without pretreatment, and detected with fluorescein isothiocyanate-conjugated anti-mouse IgM (Vector) and with biotinylated anti-rabbit-antibody (Vector), and ABC-reagent with 3-amino-9-ethylcarbazole substrate (Vector) respectively. For staining with alkaline phosphatase-conjugated α-SMA (A5691, Sigma-Aldrich), sections were incubated at 37°C, 30 minutes in 0.02% Trypsin (Difco Laboratories, Detroit, MI) in 0.05 mol/L Tris-HCl-CaCl2 (pH 7.6) and unspecific antibody binding blocked with blocking reagent in the TSA-kit (Perkin Elmer, Foster City, CA). Signal was detected by addition of Black Alkaline Phosphatase Substrate (Vector). Desmin antibody (DE-R-11, Novocastra, Newcastle, UK) and lysozyme antibody (A0099, DakoCytomation) were used after similar pretreatment as α-SMA. Desmin was detected with the ARK-kit, lysozyme and biotinylated Griffonia simplicifolia (GS) lectin II (B-1215, Vector) were detected with ABC-reagent and 3-amino-9-ethylcarbazole substrate. Staining against pepsinogen C was performed with an antibody against rat Pg-137,38 kindly provided by Dr. T. Tsukamoto (Aichi Cancer Center Research Institute, Nagoya, Japan) and staining against IF with a polyclonal rabbit antibody kindly contributed by Dr. D.H. Alpers (Washington University School of Medicine, St. Louis, MO) according to the respective recommended protocols. All immunostainings except TFF2, IF, and Ki-67 were counterstained with hematoxylin (Shandon Instant Hematoxylin, Thermo Fisher Scientific, Waltham, MA). Foveolar cells were detected with Alcian blue-Periodic acid- Schiff (AB-PAS) staining.

Quantification and Statistical Analysis

The quantified tissue sections were derived from the proximity of the major curvature. Pepsinogen altered pyloric glands (PAPG) were determined in 4.5-month-old mice by blinded scoring of 115 ± 30 pyloric glands (= bases of antral gastric units) per stained section as either positive or negative for pepsinogen C. The pylorus itself was excluded from the score, and subsequent analysis, as were weakly positive glands (2.8 ± 1.8% of all counted glands in wild-type and 3.4 ± 1.7% in Lkb1+/− mice). Sizes of TFF2 expressing cells were manually scored as the cross section area in micrographs of stained tissue sections, using ImageJ software (http://rsb.info.nih.gov/ij/). Cell numbers in the fundic stomach of aged (10- to 11.5-month-old mice) were scored from gastric units assessable in their full length. The units were selected 5 to 10 mm from the border to the squamous forestomach (the fundic-most part of murine stomach). The significance of the differences between groups was determined with Mann-Whitney U-tests, using the SPSS-software package (SPSS Inc., Chicago, IL). All values are given as mean ± SD.

GeneChip Arrays and Analysis of Gene Expression Data

Tissue samples were prepared from the fundus of 8-month-old littermate mice. Total RNA samples were collected using the RNEasy-kit (Qiagen, Valencia, CA) from pieces of wild-type stomach wall (n = 6), Lkb1+/− stomach wall (n = 6) approximately 5 mm in diameter, and from Lkb1+/− fundic polyps (n = 4). Amplification and labeling of mRNA were performed with Superscript II (Qiagen, Valencia, CA) and ENZO (Enzo Life Sciences, Farmingdale, NY) kits, according to the manufacturers’ protocols. Expression profiling was conducted with Mg-U74a2 GeneChips (Affymetrix, PaloAlto, CA), also according to the manufacturer’s instructions. Expression profiles were normalized using the GC-RMA method within the GeneSpring GX software (Agilent Technologies, Santa Clara, CA). Expression of genes reported to be enriched in foveolar cells,39 chief cells,40 and parietal cells41 were compared between wild-type and Lkb1+/− tissues. Identifiers of the published gene lists were translated to Mg-U74a2 probe set identifiers using the NetAffx batch query tool (Affymetrix, Santa Clara, CA). In addition, a random control gene list was generated from all genes containing the letters G and A in their GeneSpring GX annotation (196 identifiers). For each list, the average and standard deviations of the expression fold change were calculated, and a two-way analysis of variance test for significant differences in the expression levels between the experimental groups was performed using the R statistical analysis environment. Posthoc analysis was done with Student’s t-test.

Results

Lack of Terminal Glandular Differentiation in Lkb1+/− Polyps

Analysis of Peutz-Jeghers type gastric polyps from 10- to 11.5-month Lkb1+/− mice revealed a widened proliferative zone as recognized by Ki-67 staining (Figure 1A). Foveolar cell differentiation upwards from the proliferating zone appeared normal based on AB-PAS staining demonstrating neutral mucus-containing cells at the surface of both unaffected normal mucosa and in polyps. Also initial gland cell differentiation appeared normal based on staining with the GS lectin II (GS-lectin) in antral (Figure 1A) and fundic (Figure 1C) mucosa. This was also observed when staining polyps with an antibody against Muc6 (Supplemental Figure S1 at http://ajp.amjpathol.org). While the proportion of foveolar cells to the GS-lectin positive cells in unaffected Lkb1+/− mucosa was comparable with that of controls, it varied considerably within and among polyps. In the proximity of smooth muscle bundles, the epithelium contained a higher proportion of GS-lectin positive cells, while elsewhere the epithelium contained more foveolar cells (Figure 1B).

Figure 1.

Figure 1

Abnormally proportioned gastric units and lack of terminal gland cell differentiation in large gastric Lkb1+/− polyps with characteristic Peutz-Jeghers features. A: Comparison of proliferating (Ki-67), foveolar (Alcian blue-Periodic acid-Schiff-; AB-PAS) and glandular cells (Griffonia Simplicifolia-lectin; GS-lectin) in antral mucosa of wild-type and Lkb1+/− mice, and in an antral polyp demonstrating a widening of the proliferating, foveolar (f), and glandular (g) zones in an antral Lkb1+/− polyp, at ×200 magnification. Scale bars = 100 μm. B: Staining of an antral polyp with desmin, GS-lectin, and AB-PAS demonstrates that GS-lectin positive gland-type cells are more abundant in the vicinity of desmin staining smooth muscle bundles (arrowheads). Micrographs recorded at ×100 magnification. Size bars = 200 μm. C: A fundic polyp demonstrating lack of pepsinogen C expressing zymogenic/chief cells and parietal cells (Hydrogen-potassium adenosine-triphosphatase; H+/K+-ATPase), whereas GS-lectin positive mucous neck cells (n) and foveolar cells (AB-PAS, arrowhead) are abundant. Inset in GS-lectin panel demonstrates that GS-lectin positive mucous neck cells (n) cover the gland base adjacent to the smooth muscle stalk (m), whereas in normal glands gland the base contains chief cells (c). The surface of this polyp had suffered an erosion (asterisks).

Surprisingly, both antral and fundic polyps demonstrated either weak (n = 26/47) or no (n = 21/47) pepsinogen C staining, indicating a deficiency in antral gland, mucopeptic, and chief cells not observed in the unaffected mucosa; a fundic polyp is shown in Figure 1C. Large fundic polyps also demonstrated absence of parietal cells based on morphological analysis and H+/K+-ATPase-antibody staining (Figure 1C). Concomitantly with lack of terminally differentiated gland cells, their precursors reached the gland base, based on GS-lectin staining (Figure 1C, inset).

Absence of Pepsinogen C Identifies Incipient Peutz-Jeghers Polyps

Apart from large polyps with typical Peutz-Jeghers features, the antral mucosa of Lkb1+/− mice contains areas with varying features of hyperplasia or hyperplastic polyposis characterized as incipient polyps.36 Also in these, a deficiency in pepsinogen C staining was observed, together with a widened proliferative zone (Figure 2A, incipient polyp). Indeed, reduced pepsinogen C staining identified small incipient polyps from gastric folds, sometimes similar in appearance in tissue sections (Figure 2A, wild-type). The interglandular stroma of the incipient polyps showed increased SMA, compared with surrounding mucosa (seen in 42/72 polyps with a 0.2 to 2.0 mm diameter) associated with an increase in GS-lectin positive epithelial cells (Figure 2B) demonstrating a correlation between stromal and epithelial alterations already in incipient Peutz-Jeghers polyps.

Figure 2.

Figure 2

Aberrant epithelium and stroma in incipient Lkb1+/− polyps. A: Staining of proliferating (Ki-67) and pyloric gland cells (pepsinogen C) in antral mucosa of wild-type and Lkb1+/− mice, and in an incipient polyp (bracket). All micrographs at ×100 magnification. Scale bars = 200 μm. The normal gastric folds of wild-type antral mucosa cause glancing of the section (*) at the proliferative zone (Ki-67) without disrupting the pepsinogen C staining pattern (arrowhead). B: Decreased pepsinogen C expression in an incipient antral Lkb1+/− polyp (bracket) is associated with accumulation of neck cells (GS-lectin, arrow), and an increase in smooth muscle α-actin (SMA) expression (arrowheads; ×100 magnification. Scale bar = 200 μm. C: Pepsinogen C staining of antral mucosa in 4.5-month-old Lkb1+/− mice reveals an increase in pepsinogen C deficient glands (pepsinogen altered pyloric glands, PAPG, marked with asterisks in micrograph) compared with the wild-type. The frequencies of PAPG (PAPG %) are shown in the bar chart, n = number of glands (number of mice in parentheses). D: Triple staining with SMA (black chromogen), pepsinogen C (red chromogen), and Ki-67 (brown chromogen) of antral mucosa from a 4.5-month-old mouse demonstrates pepsinogen C deficient glands (left panel, asterisks; ×200 magnification) and Ki-67 positive proliferating cells (arrowhead) at the base of a pepsinogen C negative gland in the right panel (×630 magnification).

Pepsinogen-Deficient Glands Precede Macroscopic Polyposis

A small fraction (ca. 6%) of normal gastric pyloric glands have been found to contain strongly reduced or undetectable pepsinogen C,37 and these PAPGs increase following carcinogen exposure.37,38 To investigate possible alterations in the frequency of these altered glands in Lkb1+/− mice before polyposis, antral mucosa of young (4.5 mo) mice without detectable hyperplasia or polyps was analyzed for PAPGs (Figure 2C). The frequency was significantly increased in Lkb1+/− glands, compared with wild-type littermates (8.6 ± 2.5% vs. 6.4 ± 2.3%; P = 0045). Furthermore, concomitant staining with Ki-67 demonstrated that some pepsinogen C negative glands contained proliferative cells at the gland base (Figure 2D, arrowheads), and the frequency was significantly higher in Lkb1+/− mice 19/47 (40%) compared with controls (2/13; 15%). Excluding these focal alterations, proliferation in the unaffected antral mucosa in these young mice was not altered between Lkb1+/− (11.0 ± 2.5 Ki-67 positive cells per gland) and wild-type (11.2 ± 2.22 cells) mice.

These results indicate that the unaffected but predisposed Lkb1+/− antral epithelium in young mice contains differentiation defects similar to those detected in polyps of older mice. Interestingly, the lack of pepsinogen C and expansion of Ki-67 were not associated with any detectable increase in SMA-positive stromal cells (Figure 2D), suggesting that the epithelial defects seen in the young mice would precede stromal defects observed in incipient and large polyps. On the other hand, in mice with a conditional ablation of Lkb1 only in stromal Tagln-CRE positive cells (Lkb1lox/+; TaglnCre/+ mice8) pepsinogen C staining was undetectable in four large polyps, weak in two other large polyps (Supplemental Figure S2 at http://ajp.amjpathol.org) and similar to surrounding epithelium in two small polyps, demonstrating that Lkb1 defects limited to stroma affect gland cell differentiation as the Lkb1lox/+; TaglnCre/+ polyps mature.

Altered Epithelial Composition Reflected in Gene Expression Profiles

To further investigate the epithelial differentiation defects in Lkb1+/− polyps, we searched the literature for gene expression sets characterizing different gastric cell types, and compared wild-type, and Lkb1+/− fundic mucosa, and fundic Lkb1+/− polyps for the expression of genes in such sets described for foveolar cells,39 chief cells40 and parietal cells.41 The combined analysis of expression signatures in the three cell type sets by two-way analysis of variance demonstrated significant alterations in the Lkb1+/− polyps (P < 2.2 × 10−16), corroborating the epithelial composition changes seen in the immunohistochemical analysis.

Closer inspection of the expression profiles of Lkb1+/− polyps revealed that the expression level was below that of the wild-type mucosa in 73.0%(65/89) of the gene identifiers in the chief cell set and in 81.7%(98/120) of the parietal cell set. For the foveolar cell set, expression in the polyps was above that of the wild-type mucosa in 70.6%(303/429). Unaffected Lkb1+/− mucosa, on the other hand, was unaltered with regard to the expression of these gene sets. These results, are depicted in Figure 3A, as averages for each cell type gene set expression in polyps (black) and unaffected Lkb1+/− fundic mucosa (gray), given as fold change from the expression in wild-type mucosa. P values indicate where the averaged expression differs significantly from the wild-type expression level (normalized to 1.0 ± 0.0). Also expression of an independent set of 54 chief cell gene identifiers39 not shown in the figure, was significantly (P = 0.0018) decreased in fundic polyps (average expression fold change 0.88 ± 0.36) whereas unaffected Lkb1+/− fundic mucosa had a similar expression signature for this set as the wild-type (1.03 ± 0.16).

Figure 3.

Figure 3

Alterations in the expression of cell-type specific gene sets in Lkb1+/− tissues, and the exclusion of spasmolytic polypeptide-expressing metaplasia in Lkb1+/− fundic polyps. A: Average fold change ± SD of gene expression in indicated cell-type specific gene sets including a random set for comparison (please see Materials and Methods) in Lkb1+/− polyps (black) and unaffected fundic mucosa (gray) compared with wild-type mucosa. P values indicate the statistical significance of the difference between the wild-type and the corresponding value, as given by the Student’s t-test. B: TFF2 and IF staining of Lkb1+/− fundic polyps and wild-type mucosa, demonstrating absence of IF in the polyp (upper row) at ×100, and a magnification of the area within the white box in the upper right panel. Scale bars = 200 μm. In the lower panels, micrographs at ×630 magnification (Scale bars = 32 μm) show fundic Lkb1+/− mucosa (left panel) and only TFF2-staining gland cells in the polyp proper (middle panel) as well as a gland with a single IF-positive cell from the border of a polyp base (right panel). C: Gastrin and chromogranin A (CgA) staining of Lkb1+/− antrum, fundus and a fundic polyp provide no evidence for antralization (antrum and fundus at ×200 magnification; polyp at ×100 magnification; Scale bars = 100 μm).

Despite the similarity between wild-type and unaffected Lkb1+/− mucosa observed in the above gene expression array experiments, manual counting of marker-labeled cells in immunostained tissue sections, pointed to a small increase in foveolar cells and decrease in chief cells and mucopeptic cells (Supplemental figure S3 at http://ajp.amjpathol.org), not fully excluding minor alterations of epithelial composition also in the unaffected Lkb1+/− mucosa.

Fundic Polyp Glands Distinct from Spasmolytic Polypeptide Expressing Metaplasia

In the gastric fundus, antralization and spasmolytic polypeptide (TFF2) expressing metaplasia are known as a route to loss of glandular epithelial differentiation.42 This led us to further examine fundic Lkb1+/− polyps for features of antralization. Large gland cells expressing both TFF2 and IF in different subcellular compartments are typical for spasmolytic polypeptide-expressing metaplasia.43 Here, in fundic polyps, TFF2 expression levels were comparable with those normally found in fundic neck cells and overlapping with the pattern of GS-lectin/Muc6 staining. The size of TFF2 expressing cells was the same in polyps and in normal fundic epithelium (78.2 ± 33.1 μm2 in two fundic polyps from two Lkb1+/− mice vs. 78.7 ± 26.2 μm2 in a wild-type mouse). We also found that IF was absent from the fundic polyps similarly to pepsinogen C (Figure 3B, upper panels and lower middle panel). At the edges of their bases, 2/6 fundic polyps contained a couple of astray IF-expressing cells, which, however, had no concomitant TFF2-expression (Figure 3B lower rightmost pane). Also, staining for gastrin did not reveal ectopic expression in either fundic polyps or normal fundus of Lkb1+/− mice, whereas gastrin-producing cells were present in antral mucosa (Figure 3C), providing no further evidence for antralization in fundic Lkb1+/− polyps.

Impaired Gland Differentiation in Human Gastric Peutz-Jeghers Polyps

The defective gland cell differentiation in gastric polyps of Lkb1+/− mice next prompted us to study PJS patient polyps for similar defects. Pepsinogen C staining of five fundic and two antral PJS patient polyps was undetectable (4/7) or weak (3/7) compared with that of unaffected fundic mucosa (Figure 4A). Also the PJS patient fundic polyps contained no detectable parietal cells (Figure 4B). Chromogranin A positive cells were seen in all polyps at normal frequencies, and gastrin expression was found to be limited to antral polyps (Figure 4C), signifying that these enteroendocrine cells were present only when native to the site of the occurrence of the polyp. These results demonstrated that in PJS patient polyps, epithelial differentiation is impaired similarly as in Lkb1+/− mice.

Figure 4.

Figure 4

Impaired gland cell differentiation in human gastric Peutz-Jeghers polyps. A: Pepsinogen C or GS-lectin staining of sections from the base of an antral Peutz-Jeghers patient polyp or control gastric mucosa from a patient biopsy specimen (all micrographs at ×100 magnification; Scale bar = 200 μm). B: Staining for H+/K+-ATPase demonstrates deficiency in parietal cells in the polyp and staining for chromogranin A (CgA) shows presence of enteroendocrine cells in the base of a fundic Peutz-Jeghers patient polyp (at ×100 magnification; Scale bar = 200 μm). C: Comparison of gastrin positive cells in an antral and fundic polyp indicates presence according to the native site of occurrence (also at ×100 magnification; Scale bar = 200 μm).

Lysozyme Deficiency in Intestinal Peutz-Jeghers Polyps

While the focus of this study was on the characterization of the abundant gastric polyps, we included three jejunal mouse polyps and four duodenal PJS patient polyps to address possible misspecification along the horizontal axis of gastrointestinal differentiation, reported in juvenile polyposis.44 AB-PAS staining suggested the mucins to be correctly specified horizontally, and no detectable staining of the stomach specific TFF2 was seen in the jejunal polyps (Figure 5A). Also, while in the intestinal polyps expression of intestinal transcription factor Cdx2 was robust, no staining was detected in the gastric polyps (Figure 5B) arguing against intestinal metaplastic transformation.45 Interestingly however, Cdx2 was present also in the very basal cells of the intestinal polyp crypts (Figure 5B, intestinal polyp base), where it normally would be down-regulated to allow for Paneth cell differentiation.46 Consistent with this, direct analysis of Paneth cell differentiation using lysozyme staining demonstrated decreased or absent expression in both mouse and human polyps (Figure 5C). This demonstrated a gland cell differentiation defect also in small intestinal Peutz-Jeghers polyps.

Figure 5.

Figure 5

Correct specification into gastric versus intestinal epithelium in Peutz-Jeghers polyps and impaired Paneth cell differentiation in intestinal polyps. A: AB-PAS and TFF2 stainings of Lkb1+/− polyps from jejunum and antrum, indicating intestinal (acid) type mucin in cells with goblet morphology in the jejunal polyp consistent with normal jejunal staining pattern, and gastric (neutral) mucin on the surface of the antral polyp, as in normal gastric mucosa (micrograph at ×400; Scale bar = 50 μm). TFF2 is expressed in an antral polyp, and in the jejunal polyp there is no ectopic expression (middle panels, overlaid to the right with guides highlighting the basal surface of the epithelium in magenta, and the apical surface in blue), at ×200 magnification; Scale bar = 100 μm. B: Staining of intestinal transcription factor Cdx2 in fundic and small intestinal Lkb1+/− mucosa and polyps indicates the Cdx2 expression level in the polyps is comparable that of the native mucosa. However, Cdx2 expression extends to the crypt bottoms in the polyps (panel “Intestinal polyp base”) unlike in normal mucosa. All micrographs at ×200 magnification; Scale bar = 100 μm. C: Staining for the Paneth cell marker lysozyme shows absence in polyps both from Lkb1+/− mice (right-hand inset) and PJS patients (bottom right panel) compared with unaffected small intestine (left-hand inset and bottom left panel respectively). Mouse intestinal cross section at ×50 magnification (insets at ×200), patient polyp and control tissues at ×100 magnification (Scale bars = 200 μm).

Discussion

This investigation revealed severe disruption of gland cell differentiation in gastric Peutz-Jeghers polyps through the immunohistochemical study of gastric cell type markers as summarized in a data table (Supplemental table T1, at http://ajp.amjpathol.org), and a schematic of a gastric unit within a Peutz-Jeghers polyp, compared with normal mouse antral and fundic glands (Figure 6). Fundic glands are found in the anatomical fundus of the mouse stomach, and in the anatomical fundus and corpus of the human stomach (lower schematic, Figure 6). The disruption of gland cell differentiation was also supported by alterations in the gene expression profile of Lkb1+/− polyps, which indicated a reduction in mRNAs characterizing parietal and chief cells, and an increase in mRNAs linked to mucus producing foveolar cells.

Figure 6.

Figure 6

Schematic comparing a gastric unit in a Peutz-Jeghers polyp to fundic and antral ones. The PJS polyp gastric unit is even more elongated, with irregular morphology. (Note that normal human gastric units are larger and may also be more irregular than their mouse counterparts; several antral glands may, for example, empty into one pit.) Numerous proliferating cells in the unit neck feed into a pit region of foveolar cells and a basal region of gland-type cells (cells in transit both proliferate and contain differentiation markers). Where the voluminous stroma is enriched with myofibroblasts or smooth muscle cells, mucous neck cells (fundus) or pre-pyloric gland cell precursors (antrum) dominate the epithelium, whereas foveolar cells elsewhere. The polyp gland lacks chief and parietal cells and thus resembles the antral gland. Polyp glands, however, lack pepsinogen C expression, rendering them distinctively abnormal. Below, a schematic depiction of the gross anatomy of the mouse and the human stomach.

The most notable change observed in the Lkb1+/− gastric epithelium was a deficiency in terminally differentiated peptic gland cells, demonstrated both in antral and fundic polyps by a lack of pepsinogen C staining. Furthermore, the predisposed mucosa of young, polyp-free mice displayed a significant increase in glands lacking terminally differentiated pyloric gland cells. A similar increase in pepsinogen altered pyloric glands has been described as the first detectable change on carcinogen-induction of gastric cancer, and shown to associate with increased proliferation.37 In this study, we further showed that proliferative cells replaced the pepsinogen C expressing cells at the bases of the altered glands, suggesting disrupted homeostasis. As these changes preceded the formation of polyps and of any noticeable stromal alterations, they represent the first observed defect due to Lkb1 heterozygosity, and should thus be considered a possible causative event for Peutz-Jeghers polyp formation.

On the other hand, several observations suggest that the epithelial changes detected are secondary to stromal alterations. Conditional deletion of Lkb1 in stromal smooth muscle cells (Lkb1lox/+; TaglnCre/+) was recently shown to cause a polyposis very similar to that observed in Lkb1+/− mice.8 Also, in this study we observed an increase in SMA-positive stromal cells in incipient polyps (Figure 2). This is consistent with a model, wherein epithelial differentiation defects would be secondary to altered stromal-epithelial signaling necessary for peptic cell differentiation.28,47 Here, similarly disrupted gland cell differentiation in polyps from Lkb1+/− mice and from Lkb1lox/+; TaglnCre/+ mice supported such a model. Although Lkb1lox/+; TaglnCre/+ polyps thus appear indistinguishable from Lkb1+/− polyps also in this regard, they are smaller and occur in only 61% of mice at 11 months, compared with 100% in the Lkb1+/− mice.8 Based on these observations, it is thus possible that in Lkb1+/− mice, here undetected stromal alterations precede epithelial differentiation defects, which in turn are even further enhanced by concomitant epithelial Lkb1 heterozygosity, contributing to increased polyp initiation and growth.

Considering the order in which the differentiation defects may occur in the Lkb1+/− gastric epithelium one may note that parietal cell loss is well described to disrupt both gland cell and foveolar cell differentiation.48 We consider this mechanism of failing epithelial differentiation to be unlikely in the Lkb1+/− mice, for three reasons: i) the parietal cell defects in the fundus were limited to polyps, whereas peptic cell alterations were seen in other predisposed epithelium (Figure 2, Figure 3); ii) gland cell differentiation was disrupted also in the antral mucosa, independently of fundic polyps; iii) no defects in foveolar cell differentiation were observed. Instead we propose a mechanism, through which global forward differentiation of the gland cell lineages ceases before the cells have specialized in their secretory functions.

With a sudden loss of parietal cells one would also have expected a process of antralization to drive dedifferentiation in the fundic mucosa.42 That is, fundic Peutz-Jeghers polyps would have contained antral metaplasia/spasmolytic polypeptide-expressing metaplasia, characterized by larger than normal epithelial cells co-expressing TFF2 and IF in separate granules.43 This we did not observe. The normal distribution of gastrin expression also argued against antralization, and the site-appropriate patterns of AB-PAS and Cdx2 staining gave no support for metaplastic differentiation in neither stomach nor intestinal polyps. By contrast these studies revealed a defect also in Paneth cell differentiation in intestinal polyps, revealing a more general disruption of epithelial differentiation in Peutz-Jeghers polyposis and suggesting similarities in the differentiation programs of the downward migrating exocrine cells of the stomach and small intestine. Curiously, Paneth cell differentiation is also disrupted on complete ablation of Lkb1 in intestinal epithelium before a larger disruption of epithelial architecture and lethality.49

Contrary to current understanding,6,34,50 this study demonstrated that Peutz-Jeghers polyps do not contain all epithelial cell types and lineages native to their site of occurrence. Some epithelial alterations were seen also in unaffected Lkb1+/− mucosa, however, the Peutz-Jeghers and incipient polyp epithelium was much less differentiated and more proliferative. This is in agreement with a recent report of increased proliferation in intestinal Peutz-Jeghers patient polyps,51 which also described an expansion of the proliferative zone in unaffected small intestinal epithelium. We saw no such expansion in unaffected Lkb1+/− stomach epithelium. However, we performed the analysis in a different setting, before the onset of macroscopic polyposis in young mice to identify alterations that would not be secondary to polyposis.

The discovery of defective peptic cell differentiation in Peutz-Jeghers polyps gives the opportunity to hypothesize that differentiation-promoting agents might slow polyp growth. Interestingly, glucocorticoids both induce peptic cell differentiation26,27,28 and reduce cyclooxygenase-2 expression,52 which previously has been noted to suppress PJS polyposis.36

Acknowledgments

We thank Dr. Chie Furihata and Dr. Tetsuya Tsukamoto for kindly providing the antibody against pepsinogen C, Dr. George Elia and Dr. Nicholas A. Wright for providing the TFF2 antibody, Dr. David H. Alpers for the IF antibody, and Ms. Outi Kokkonen for assisting with the immunostaining.

Footnotes

Address reprint requests to Tomi P. Mäkelä, M.D., Ph.D., Institute of Biotechnology and Genome-Scale Biology Research Program, P.O. Box 56 (Biocenter 1), 00014 University of Helsinki, Helsinki, Finland. E-mail: Tomi.Makela@helsinki.fi.

Supported by grants from the Academy of Finland, the Sigrid Juselius Foundation, the Finnish Cancer Foundation, the European Union Sixth Framework Programme grant European Network for Functional Integration (LSHG-CT-2005-518254), the Maud Kuistila Foundation, the KA Johansson Foundation, and Finska Läkaresällskapet r.f. L.U. is a student of the Helsinki Biomedical Graduate School.

Supplemental material for this article can be found on http://ajp.amjpathol.org.

References

  1. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Hoglund P, Jarvinen H, Kristo P, Pelin K, Ridanpaa M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 1998;391:184–187. doi: 10.1038/34432. [DOI] [PubMed] [Google Scholar]
  2. Mehenni H, Resta N, Park JG, Miyaki M, Guanti G, Costanza MC. Cancer risks in LKB1 germline mutation carriers. Gut. 2006;55:984–990. doi: 10.1136/gut.2005.082990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hearle N, Schumacher V, Menko FH, Olschwang S, Boardman LA, Gille JJ, Keller JJ, Westerman AM, Scott RJ, Lim W, Trimbath JD, Giardiello FM, Gruber SB, Offerhaus GJ, de Rooij FW, Wilson JH, Hansmann A, Moslein G, Royer-Pokora B, Vogel T, Phillips RK, Spigelman AD, Houlston RS. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res. 2006;12:3209–3215. doi: 10.1158/1078-0432.CCR-06-0083. [DOI] [PubMed] [Google Scholar]
  4. Baas AF, Smit L, Clevers H. LKB1 tumor suppressor protein: PARtaker in cell polarity. Trends Cell Biol. 2004;14:312–319. doi: 10.1016/j.tcb.2004.04.001. [DOI] [PubMed] [Google Scholar]
  5. Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, Cruz-Correa M, Offerhaus JA. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119:1447–1453. doi: 10.1053/gast.2000.20228. [DOI] [PubMed] [Google Scholar]
  6. Rintala A. The histological appearance of gastrointestinal polyps in the Peutz-Jeghers syndrome. Acta Chir Scand. 1959;117:366–373. [PubMed] [Google Scholar]
  7. Rossi DJ, Ylikorkala A, Korsisaari N, Salovaara R, Luukko K, Launonen V, Henkemeyer M, Ristimaki A, Aaltonen LA, Makela TP. Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc Natl Acad Sci USA. 2002;99:12327–12332. doi: 10.1073/pnas.192301399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Katajisto P, Vaahtomeri K, Ekman N, Ventela E, Ristimaki A, Bardeesy N, Feil R, DePinho RA, Makela TP. LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis. Nat Genet. 2008;40:455–459. doi: 10.1038/ng.98. [DOI] [PubMed] [Google Scholar]
  9. Bleuming SA, He XC, Kodach LL, Hardwick JC, Koopman FA, Ten Kate FJ, van Deventer SJ, Hommes DW, Peppelenbosch MP, Offerhaus GJ, Li L, van den Brink GR. Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice. Cancer Res. 2007;67:8149–8155. doi: 10.1158/0008-5472.CAN-06-4659. [DOI] [PubMed] [Google Scholar]
  10. Brittan M, Wright NA. Stem cell in gastrointestinal structure and neoplastic development. Gut. 2004;53:899–910. doi: 10.1136/gut.2003.025478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mishra L, Shetty K, Tang Y, Stuart A, Byers SW. The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene. 2005;24:5775–5789. doi: 10.1038/sj.onc.1208924. [DOI] [PubMed] [Google Scholar]
  12. Bleuming SA, Kodach LL, Garcia Leon MJ, Richel DJ, Peppelenbosch MP, Reitsma PH, Hardwick JC, van den Brink GR. Altered bone morphogenetic protein signalling in the Helicobacter pylori-infected stomach. J Pathol. 2006;209:190–197. doi: 10.1002/path.1976. [DOI] [PubMed] [Google Scholar]
  13. Byun T, Karimi M, Marsh JL, Milovanovic T, Lin F, Holcombe RF. Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis. J Clin Pathol. 2005;58:515–519. doi: 10.1136/jcp.2004.018598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fukaya M, Isohata N, Ohta H, Aoyagi K, Ochiya T, Saeki N, Yanagihara K, Nakanishi Y, Taniguchi H, Sakamoto H, Shimoda T, Nimura Y, Yoshida T, Sasaki H. Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer. Gastroenterology. 2006;131:14–29. doi: 10.1053/j.gastro.2006.05.008. [DOI] [PubMed] [Google Scholar]
  15. Modlin IM, Kidd M, Lye KD, Wright NA. Gastric stem cells: an update. Keio J Med. 2003;52:134–137. doi: 10.2302/kjm.52.134. [DOI] [PubMed] [Google Scholar]
  16. Karam SM. Lineage commitment and maturation of epithelial cells in the gut. Front Biosci. 1999;4:D286–D298. doi: 10.2741/karam. [DOI] [PubMed] [Google Scholar]
  17. Karam SM, Straiton T, Hassan WM, Leblond CP. Defining epithelial cell progenitors in the human oxyntic mucosa. Stem Cells. 2003;21:322–336. doi: 10.1634/stemcells.21-3-322. [DOI] [PubMed] [Google Scholar]
  18. Lee ER, Trasler J, Dwivedi S, Leblond CP. Division of the mouse gastric mucosa into zymogenic and mucous regions on the basis of gland features. Am J Anat. 1982;164:187–207. doi: 10.1002/aja.1001640302. [DOI] [PubMed] [Google Scholar]
  19. Furihata C, Iwasaki Y, Sugimura T, Tatematsu M, Takahashi M. Differentiation of pepsinogen-producing cells in the fundic and pyloric mucosa of developing rats. Cell Differ. 1973;2:179–189. doi: 10.1016/0045-6039(73)90019-5. [DOI] [PubMed] [Google Scholar]
  20. Samloff IM. Slow moving protease and the seven pepsinogens. Electrophoretic demontration of the existence of eight proteolytic fractions in human gastric mucosa. Gastroenterology. 1969;57:659–669. [PubMed] [Google Scholar]
  21. Kouznetsova I, Laubinger W, Kalbacher H, Kalinski T, Meyer F, Roessner A, Hoffmann W. Biosynthesis of gastrokine-2 in the human gastric mucosa: restricted spatial expression along the antral gland axis and differential interaction with TFF1, TFF2, and mucins. Cell Physiol Biochem. 2007;20:899–908. doi: 10.1159/000110450. [DOI] [PubMed] [Google Scholar]
  22. Shao J, Sartor RB, Dial E, Lichtenberger LM, Schepp W, Alpers DH. Expression of intrinsic factor in rat and murine gastric mucosal cell lineages is modified by inflammation. Am J Pathol. 2000;157:1197–1205. doi: 10.1016/s0002-9440(10)64635-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Howard TA, Misra DN, Grove M, Becich MJ, Shao JS, Gordon M, Alpers DH. Human gastric intrinsic factor expression is not restricted to parietal cells. J Anat. 1996;189 (Pt 2):303–313. [PMC free article] [PubMed] [Google Scholar]
  24. Ramsey VG, Doherty JM, Chen CC, Stappenbeck TS, Konieczny SF, Mills JC. The maturation of mucus-secreting gastric epithelial progenitors into digestive-enzyme secreting zymogenic cells requires Mist1. Development. 2007;134:211–222. doi: 10.1242/dev.02700. [DOI] [PubMed] [Google Scholar]
  25. Li Q, Karam SM, Coerver KA, Matzuk MM, Gordon JI. Stimulation of activin receptor II signaling pathways inhibits differentiation of multiple gastric epithelial lineages. Mol Endocrinol. 1998;12:181–192. doi: 10.1210/mend.12.2.0060. [DOI] [PubMed] [Google Scholar]
  26. Tseng CC, Schmidt KL, Johnson LR. Hormonal effects on development of the secretory apparatus of chief cells. Am J Physiol. 1987;253:G274–G283. doi: 10.1152/ajpgi.1987.253.3.G274. [DOI] [PubMed] [Google Scholar]
  27. Tsukada S, Ichinose M, Tatematsu M, Tezuka N, Yonezawa S, Kakei N, Matsushima M, Miki K, Kurokawa K, Kageyama T, Takahashi K, Famaci H. Glucocorticoids inhibit the proliferation of mucosal cells and enhance the expression of a gene for pepsinogen and other markers of differentiation in the stomach mucosa of the adult rat. Biochem Biophys Res Commun. 1994;202:1–9. doi: 10.1006/bbrc.1994.1885. [DOI] [PubMed] [Google Scholar]
  28. Tsukada S, Ichinose M, Yahagi N, Matsubara Y, Yonezawa S, Shiokawa K, Furihata C, Miki K, Fukamachi H. Induction of precocious pepsinogen synthesis by glucocorticoids in fetal rat gastric epithelium in organ culture: importance of mesenchyme for epithelial differentiation. Differentiation. 1998;62:239–247. doi: 10.1046/j.1432-0436.1998.6250239.x. [DOI] [PubMed] [Google Scholar]
  29. Leedham SJ, Brittan M, Preston SL, McDonald SA, Wright NA. The stomach periglandular fibroblast sheath: all present and correct. Gut. 2006;55:295–296. [PMC free article] [PubMed] [Google Scholar]
  30. Powell DW, Adegboyega PA, Di Mari JF, Mifflin RC. Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. Am J Physiol Gastrointest Liver Physiol. 2005;289:G2–G7. doi: 10.1152/ajpgi.00075.2005. [DOI] [PubMed] [Google Scholar]
  31. Mutoh H, Sakurai S, Satoh K, Osawa H, Tomiyama T, Kita H, Yoshida T, Tamada K, Yamamoto H, Isoda N, Ido K, Sugano K. Pericryptal fibroblast sheath in intestinal metaplasia and gastric carcinoma. Gut. 2005;54:33–39. doi: 10.1136/gut.2004.042770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Nakayama H, Enzan H, Miyazaki E, Toi M. Alpha smooth muscle actin positive stromal cells in gastric carcinoma. J Clin Pathol. 2002;55:741–744. doi: 10.1136/jcp.55.10.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. McCaig C, Duval C, Hemers E, Steele I, Pritchard DM, Przemeck S, Dimaline R, Ahmed S, Bodger K, Kerrigan DD, Wang TC, Dockray GJ, Varro A. The role of matrix metalloproteinase-7 in redefining the gastric microenvironment in response to Helicobacter pylori. Gastroenterology. 2006;130:1754–1763. doi: 10.1053/j.gastro.2006.02.031. [DOI] [PubMed] [Google Scholar]
  34. Estrada R, Spjut HJ. Hamartomatous polyps in Peutz-Jeghers syndrome. A light-, histochemical, and electron-microscopic study. Am J Surg Pathol. 1983;7:747–754. [PubMed] [Google Scholar]
  35. Ylikorkala A, Rossi DJ, Korsisaari N, Luukko K, Alitalo K, Henkemeyer M, Makela TP. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science. 2001;293:1323–1326. doi: 10.1126/science.1062074. [DOI] [PubMed] [Google Scholar]
  36. Udd L, Katajisto P, Rossi DJ, Lepisto A, Lahesmaa AM, Ylikorkala A, Jarvinen HJ, Ristimaki AP, Makela TP. Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2. Gastroenterology. 2004;127:1030–1037. doi: 10.1053/j.gastro.2004.07.059. [DOI] [PubMed] [Google Scholar]
  37. Tatematsu M, Mutai M, Aoki T, de Camargo JL, Furihata C, Ito N. Proliferation kinetics of pepsinogen altered pyloric gland cells in rats treated with N-methyl-N′-nitro-N-nitrosoguanidine. Carcinogenesis. 1989;10:907–911. doi: 10.1093/carcin/10.5.907. [DOI] [PubMed] [Google Scholar]
  38. Yamamoto M, Furihata C, Ogiu T, Tsukamoto T, Inada K, Hirano K, Tatematsu M. Independent variation in susceptibilities of six different mouse strains to induction of pepsinogen-altered pyloric glands and gastric tumor intestinalization by N-methyl-N-nitrosourea. Cancer Lett. 2002;179:121–132. doi: 10.1016/s0304-3835(02)00013-7. [DOI] [PubMed] [Google Scholar]
  39. Mueller A, Merrell DS, Grimm J, Falkow S. Profiling of microdissected gastric epithelial cells reveals a cell type-specific response to Helicobacter pylori infection. Gastroenterology. 2004;127:1446–1462. doi: 10.1053/j.gastro.2004.08.054. [DOI] [PubMed] [Google Scholar]
  40. Mills JC, Andersson N, Stappenbeck TS, Chen CC, Gordon JI. Molecular characterization of mouse gastric zymogenic cells. J Biol Chem. 2003;278:46138–46145. doi: 10.1074/jbc.M308385200. [DOI] [PubMed] [Google Scholar]
  41. Mills JC, Syder AJ, Hong CV, Guruge JL, Raaii F, Gordon JI. A molecular profile of the mouse gastric parietal cell with and without exposure to Helicobacter pylori. Proc Natl Acad Sci USA. 2001;98:13687–13692. doi: 10.1073/pnas.231332398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Goldenring JR, Nomura S. Differentiation of the gastric mucosa III. Animal models of oxyntic atrophy and metaplasia. Am J Physiol Gastrointest Liver Physiol. 2006;291:G999–G1004. doi: 10.1152/ajpgi.00187.2006. [DOI] [PubMed] [Google Scholar]
  43. Yamaguchi H, Goldenring JR, Kaminishi M, Lee JR. Association of spasmolytic polypeptide-expressing metaplasia with carcinogen administration and oxyntic atrophy in rats. Lab Invest. 2002;82:1045–1052. doi: 10.1097/01.lab.0000022225.45996.21. [DOI] [PubMed] [Google Scholar]
  44. Barros R, Mendes N, Howe JR, Reis CA, de Bolos C, Carneiro F, David L, Almeida R. Juvenile polyps have gastric differentiation with MUC5AC expression and downregulation of CDX2 and SMAD4. Histochem Cell Biol. 2009;131 (6):765–772. doi: 10.1007/s00418-009-0579-z. [DOI] [PubMed] [Google Scholar]
  45. Gutierrez-Gonzalez L, Wright NA. Biology of intestinal metaplasia in 2008: More than a simple phenotypic alteration, Dig Liver Dis. 2008;40 (7):510–522. doi: 10.1016/j.dld.2008.02.029. [DOI] [PubMed] [Google Scholar]
  46. Blache P, van de Wetering M, Duluc I, Domon C, Berta P, Freund JN, Clevers H, Jay P. SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol. 2004;166:37–47. doi: 10.1083/jcb.200311021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Fukamachi H, Ichinose M, Ishihama S, Tsukada S, Yasugi S, Shiokawa K, Furihata C, Yonezawa S, Miki K. Fetal rat glandular stomach epithelial cells differentiate into surface mucous cells which express cathepsin E in the absence of mesenchymal cells in primary culture. Differentiation. 1994;56:83–89. doi: 10.1046/j.1432-0436.1994.56120083.x. [DOI] [PubMed] [Google Scholar]
  48. Li Q, Karam SM, Gordon JI. Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J Biol Chem. 1996;271:3671–3676. [PubMed] [Google Scholar]
  49. Shorning BY, Zabkiewicz J, McCarthy A, Pearson HB, Winton DJ, Sansom OJ, Ashworth A, Clarke AR. Lkb1 deficiency alters goblet and paneth cell differentiation in the small intestine. PLoS ONE. 2009;4:e4264. doi: 10.1371/journal.pone.0004264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Tobi M. Polyps as biomarkers for colorectal neoplasia. Front Biosci. 1999;4:D329–D338. doi: 10.2741/tobi. [DOI] [PubMed] [Google Scholar]
  51. de Leng WW, Jansen M, Keller JJ, de Gijsel M, Milne AN, Morsink FH, Weterman MA, Iacobuzio-Donahue CA, Clevers HC, Giardiello FM, Offerhaus GJ. Peutz-Jeghers syndrome polyps are polyclonal with expanded progenitor cell compartment. Gut. 2007;56:1475–1476. doi: 10.1136/gut.2007.128132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Ristimaki A, Narko K, Hla T. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J. 1996;318 (Pt 1):325–331. doi: 10.1042/bj3180325. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES